Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

2016 "We Work For Health" Champion Award Winners

March 9, 2016

Employees from biopharmaceutical companies are honored as “We Work For Health Champions” for their extraordinary efforts in policy advocacy and community service.

Read More

PhRMA Statement on Medicare Part B Drugs and Changes

March 8, 2016

PhRMA issues a statement in reaction to a released ASPE Issue Brief on Medicare Part B drugs and proposed Part B changes.

Read More

PhRMA Statement on Prescription Drug Spending Trends

March 8, 2016

PhRMA issues a statement on ASPE Observations' on trends in prescription drug spending issue brief.

Read More

New Medicines in Development for Osteoporosis

March 7, 2016

Nearly 54 million Americans live with osteoporosis or low bone density, and that number is expected to reach more than 71 million by 2030.

Read More

PhRMA Statement BMJ Physician-Administered Drug Study

March 1, 2016

PhRMA released a statement in reaction to a study published in BMJ on physician-administered drugs.

Read More

MyOldMeds Campaign Launches in Massachusetts

February 24, 2016

Local law enforcement representatives and PhRMA were joined by Governor Charlie Baker to formally launch "MyOldMeds Massachusetts."

Read More

Rodger Currie to Lead Advocacy Efforts at PhRMA

January 19, 2016

Rodger Currie will join PhRMA as executive vice president for advocacy, leading federal, state and international government affairs and alliance development.

Read More

PhRMA Appoints Amy Jackson as New Japan Representative

January 7, 2016

Ms. Jackson will advocate for America’s research-based pharmaceutical companies on government, economic and health care policy matters in Japan.

Read More

Statement on the Trans-Pacific Partnership Negotiations

October 5, 2015

PhRMA believes that strong intellectual property protection is necessary for the discovery and development of new treatments and therapies for patients.

Read More

Stephen J. Ubl to Lead PhRMA as Next President and CEO

September 25, 2015

Stephen J. Ubl joins PhRMA after more than ten years as the president and CEO of AdvaMed, the world’s largest medical technology association.

Read More